Healthcare provider profile · identity verified

Mallory Sprague, MD

Allopathic & Osteopathic Physicians|Family Medicine · POTSDAM, NY · NPI 1366891632

Profile state: payments and partd Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

CMS Open Payments records show Mallory Sprague, MD received $14.53 in general payments during 2025 across 1 reported records.

Amgen Inc. accounted for 100.0% of that reported general-payment amount.

The Open Payments records used for this analysis explicitly named 2 associated products.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

$14.53

1 reported records · 1 companies

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Who paid this doctor?

Companies in 2025 General Payments

Reported company	Canonical company	Amount	Share	Records	Year
Amgen Inc.	Unresolved — no canonical attribution shown	$14.53	100.0%	1	2025

What were the payments for?

Payment categories

Category	Amount	Records
Food and Beverage	$14.53	1

A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.

Analysis 1 · Payment-linked products

Products named in Open Payments records

Reported product	Type	Reported company	Related amount*	Records	Year
OTEZLA Normalized: otezla	Drug	Amgen Inc.	$14.53	1	2025
Source payment records 2025-07-30 · Amgen Inc. · $14.53 · Open Payments source
REPATHA Normalized: repatha	Biological	Amgen Inc.	$14.53	1	2025
Source payment records 2025-07-30 · Amgen Inc. · $14.53 · Open Payments source

* Product-associated amounts are non-additive because one payment record may name more than one product.

These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.

Public prescribing for products named in payments

No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	354	106
Levothyroxine Sodium	Levothyroxine Sodium	346	82
Amlodipine Besylate	Amlodipine Besylate	341	97
Lisinopril	Lisinopril	333	89
Omeprazole	Omeprazole	330	82
Rosuvastatin Calcium	Rosuvastatin Calcium	254	67
Metoprolol Succinate	Metoprolol Succinate	234	63
Losartan Potassium	Losartan Potassium	205	56
Hydrochlorothiazide	Hydrochlorothiazide	190	55
Gabapentin	Gabapentin	185	45
Furosemide	Furosemide	183	47
Pantoprazole Sodium	Pantoprazole Sodium	170	50
Metformin Hcl	Metformin Hcl	166	45
Eliquis	Apixaban	123	35
Metoprolol Tartrate	Metoprolol Tartrate	120	33
Simvastatin	Simvastatin	109	35
Sertraline Hcl	Sertraline Hcl	107	23
Albuterol Sulfate Hfa	Albuterol Sulfate	98	34
Famotidine	Famotidine	97	23
Tamsulosin Hcl	Tamsulosin Hcl	92	27
Fluticasone Propionate	Fluticasone Propionate	89	27
Trazodone Hcl	Trazodone Hcl	86	23
Potassium Chloride	Potassium Chloride	85	26
Alendronate Sodium	Alendronate Sodium	78	12
Escitalopram Oxalate	Escitalopram Oxalate	76	22
Metformin Hcl Er	Metformin Hcl	72	24
Duloxetine Hcl	Duloxetine Hcl	71	18
Pravastatin Sodium	Pravastatin Sodium	70	22
Allopurinol	Allopurinol	68	23
Carvedilol	Carvedilol	60	13
Ropinirole Hcl	Ropinirole Hcl	59	12
Nystatin	Nystatin	56	21
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	55	16
Montelukast Sodium	Montelukast Sodium	54	18
Ezetimibe	Ezetimibe	51	17
Mounjaro	Tirzepatide	48	suppressed
Ozempic	Semaglutide	47	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	46	suppressed
Ramipril	Ramipril	44	suppressed
Alprazolam	Alprazolam	43	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	42	suppressed
Bupropion Xl	Bupropion Hcl	41	14
Buspirone Hcl	Buspirone Hcl	41	12
Januvia	Sitagliptin Phosphate	39	suppressed
Carbamazepine	Carbamazepine	37	suppressed
Xarelto	Rivaroxaban	37	suppressed
Citalopram Hbr	Citalopram Hydrobromide	34	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	34	11
Atenolol	Atenolol	33	11
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	33	suppressed
Loperamide	Loperamide Hcl	33	suppressed
Mirtazapine	Mirtazapine	33	suppressed
Spironolactone	Spironolactone	33	11
Topiramate	Topiramate	33	suppressed
Warfarin Sodium	Warfarin Sodium	33	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	32	suppressed
Jardiance	Empagliflozin	32	11
Irbesartan	Irbesartan	31	12
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	30	suppressed
Tramadol Hcl	Tramadol Hcl	30	suppressed
Trulicity	Dulaglutide	30	suppressed
Celecoxib	Celecoxib	29	suppressed
Ibuprofen	Ibuprofen	29	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	29	suppressed
Symbicort	Budesonide/Formoterol Fumarate	29	suppressed
Clopidogrel	Clopidogrel Bisulfate	28	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	27	suppressed
Lorazepam	Lorazepam	27	suppressed
Meloxicam	Meloxicam	27	suppressed
Pregabalin	Pregabalin	27	suppressed
Synthroid	Levothyroxine Sodium	27	suppressed
Finasteride	Finasteride	26	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	26	suppressed
Lovastatin	Lovastatin	26	suppressed
Ondansetron Odt	Ondansetron	26	suppressed
Oxycodone Hcl	Oxycodone Hcl	26	suppressed
Dilantin	Phenytoin Sodium Extended	24	suppressed
Lactulose	Lactulose	24	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	24	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	24	suppressed
Azelastine Hcl	Azelastine Hcl	23	suppressed
Fluconazole	Fluconazole	23	18
Glipizide	Glipizide	23	suppressed
Nifedipine Er	Nifedipine	23	suppressed
Nitroglycerin	Nitroglycerin	23	13
Chlorthalidone	Chlorthalidone	22	11
Morphine Sulfate Er	Morphine Sulfate	22	suppressed
Propranolol Hcl	Propranolol Hcl	22	suppressed
Rybelsus	Semaglutide	22	suppressed
Donepezil Hcl	Donepezil Hcl	21	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	21	16
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	21	suppressed
Incruse Ellipta	Umeclidinium Bromide	21	suppressed
Valacyclovir	Valacyclovir Hcl	21	suppressed
Euthyrox	Levothyroxine Sodium	20	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	20	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	20	suppressed
Clonazepam	Clonazepam	19	suppressed
Fenofibrate	Fenofibrate	19	suppressed
Invokana	Canagliflozin	19	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	19	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	19	11
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	19	suppressed
Baclofen	Baclofen	18	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	18	16
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	18	suppressed
Risperidone	Risperidone	18	suppressed
Dutasteride	Dutasteride	17	suppressed
Meclizine Hcl	Meclizine Hcl	17	suppressed
Sucralfate	Sucralfate	17	suppressed
Olanzapine	Olanzapine	16	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	15	suppressed
Aripiprazole	Aripiprazole	15	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	15	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	15	suppressed
Ondansetron Hcl	Ondansetron Hcl	15	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	14	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	14	14
Bupropion Hcl Sr	Bupropion Hcl	14	suppressed
Divalproex Sodium	Divalproex Sodium	14	suppressed
Glimepiride	Glimepiride	14	suppressed
Primidone	Primidone	14	suppressed
Breo Ellipta	Fluticasone/Vilanterol	13	suppressed
Clonidine Hcl	Clonidine Hcl	13	suppressed
Paroxetine Hcl	Paroxetine Hcl	13	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	13	suppressed
Propranolol Hcl Er	Propranolol Hcl	13	suppressed
Amoxicillin	Amoxicillin	12	suppressed
Benztropine Mesylate	Benztropine Mesylate	12	suppressed
Desloratadine	Desloratadine	12	suppressed
Enalapril Maleate	Enalapril Maleate	12	suppressed
Hydromorphone Hcl	Hydromorphone Hcl	12	suppressed
Prazosin Hcl	Prazosin Hcl	12	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	12	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	11	suppressed
Cephalexin	Cephalexin	11	suppressed
Depakote Er	Divalproex Sodium	11	suppressed
Klor-Con M10	Potassium Chloride	11	suppressed
Methocarbamol	Methocarbamol	11	suppressed
Promethazine Hcl	Promethazine Hcl	11	suppressed
Tresiba Flextouch U-200	Insulin Degludec	11	suppressed
Verapamil Sr	Verapamil Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	$14.53 · 1 records	Amgen Inc.	OTEZLA, REPATHA	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error